<?xml version="1.0"?>
<presentation title="08 Thawee Ratanachu-ek" width="960.0000000" height="540.0000000" thmbWidth="78.0000000" thmbHeight="44.0000000" frameRate="24.0000000" looping="0" startingSlideShow="" pptVersion="2010" type="compound" hasExternalAudio="0" uid="{A3E64F39-58CB-4A56-9C25-C3D52F6F9190}">
	<presenters>
		<presenter name="Thawee Ratanachu-ek" title="Thailand" email="" web="" phone="" photoAssetId="">
			<bio>EUS for portal hypertension and varix management</bio>
		</presenter>
	</presenters>
	<references/>
	<soundAssets>
		<soundAsset id="sndAsset0" src="sound1.mp3" embedded="0" size="157197" duration="19649"/>
		<soundAsset id="sndAsset1" src="sound2.mp3" embedded="0" size="603996" duration="75499"/>
		<soundAsset id="sndAsset2" src="sound3.mp3" embedded="0" size="125432" duration="15679"/>
		<soundAsset id="sndAsset3" src="sound4.mp3" embedded="0" size="95966" duration="11995"/>
		<soundAsset id="sndAsset4" src="sound5.mp3" embedded="0" size="135672" duration="16959"/>
		<soundAsset id="sndAsset5" src="sound6.mp3" embedded="0" size="337129" duration="42141"/>
		<soundAsset id="sndAsset6" src="sound7.mp3" embedded="0" size="166183" duration="20772"/>
		<soundAsset id="sndAsset7" src="sound8.mp3" embedded="0" size="147793" duration="18474"/>
		<soundAsset id="sndAsset8" src="sound9.mp3" embedded="0" size="292825" duration="36603"/>
		<soundAsset id="sndAsset9" src="sound10.mp3" embedded="0" size="194605" duration="24325"/>
		<soundAsset id="sndAsset10" src="sound11.mp3" embedded="0" size="166183" duration="20772"/>
		<soundAsset id="sndAsset11" src="sound12.mp3" embedded="0" size="269001" duration="33625"/>
		<soundAsset id="sndAsset12" src="sound13.mp3" embedded="0" size="395643" duration="49455"/>
		<soundAsset id="sndAsset13" src="sound14.mp3" embedded="0" size="300139" duration="37517"/>
		<soundAsset id="sndAsset14" src="sound15.mp3" embedded="0" size="300557" duration="37569"/>
		<soundAsset id="sndAsset15" src="sound16.mp3" embedded="0" size="104952" duration="13119"/>
		<soundAsset id="sndAsset16" src="sound17.mp3" embedded="0" size="193769" duration="24221"/>
		<soundAsset id="sndAsset17" src="sound18.mp3" embedded="0" size="180812" duration="22601"/>
		<soundAsset id="sndAsset18" src="sound19.mp3" embedded="0" size="188544" duration="23568"/>
		<soundAsset id="sndAsset19" src="sound20.mp3" embedded="0" size="196067" duration="24508"/>
		<soundAsset id="sndAsset20" src="sound21.mp3" embedded="0" size="317067" duration="39633"/>
		<soundAsset id="sndAsset21" src="sound22.mp3" embedded="0" size="113729" duration="14216"/>
		<soundAsset id="sndAsset22" src="sound23.mp3" embedded="0" size="221981" duration="27747"/>
		<soundAsset id="sndAsset23" src="sound24.mp3" embedded="0" size="146121" duration="18265"/>
		<soundAsset id="sndAsset24" src="sound25.mp3" embedded="0" size="231385" duration="28923"/>
		<soundAsset id="sndAsset25" src="sound26.mp3" embedded="0" size="577664" duration="72208"/>
		<soundAsset id="sndAsset26" src="sound27.mp3" embedded="0" size="799182" duration="99897"/>
		<soundAsset id="sndAsset27" src="sound28.mp3" embedded="0" size="386866" duration="48358"/>
		<soundAsset id="sndAsset28" src="sound29.mp3" embedded="0" size="479026" duration="59878"/>
		<soundAsset id="sndAsset29" src="sound30.mp3" embedded="0" size="170990" duration="21373"/>
		<soundAsset id="sndAsset30" src="sound31.mp3" embedded="0" size="294497" duration="36812"/>
		<soundAsset id="sndAsset31" src="sound32.mp3" embedded="0" size="480698" duration="60087"/>
		<soundAsset id="sndAsset32" src="sound33.mp3" embedded="0" size="242670" duration="30333"/>
		<soundAsset id="sndAsset33" src="sound34.mp3" embedded="0" size="260433" duration="32554"/>
		<soundAsset id="sndAsset34" src="sound35.mp3" embedded="0" size="334203" duration="41775"/>
	</soundAssets>
	<sharedAssetsLibrary src="assets.swf"/>
	<graphicAssets>
		<graphicAsset id="imgAsset0" src="thmb1.swf" embedded="0"/>
		<graphicAsset id="imgAsset1" src="thmb2.swf" embedded="0"/>
		<graphicAsset id="imgAsset2" src="thmb3.swf" embedded="0"/>
		<graphicAsset id="imgAsset3" src="thmb4.swf" embedded="0"/>
		<graphicAsset id="imgAsset4" src="thmb5.swf" embedded="0"/>
		<graphicAsset id="imgAsset5" src="thmb6.swf" embedded="0"/>
		<graphicAsset id="imgAsset6" src="thmb7.swf" embedded="0"/>
		<graphicAsset id="imgAsset7" src="thmb8.swf" embedded="0"/>
		<graphicAsset id="imgAsset8" src="thmb9.swf" embedded="0"/>
		<graphicAsset id="imgAsset9" src="thmb10.swf" embedded="0"/>
		<graphicAsset id="imgAsset10" src="thmb11.swf" embedded="0"/>
		<graphicAsset id="imgAsset11" src="thmb12.swf" embedded="0"/>
		<graphicAsset id="imgAsset12" src="thmb13.swf" embedded="0"/>
		<graphicAsset id="imgAsset13" src="thmb14.swf" embedded="0"/>
		<graphicAsset id="imgAsset14" src="thmb15.swf" embedded="0"/>
		<graphicAsset id="imgAsset15" src="thmb16.swf" embedded="0"/>
		<graphicAsset id="imgAsset16" src="thmb17.swf" embedded="0"/>
		<graphicAsset id="imgAsset17" src="thmb18.swf" embedded="0"/>
		<graphicAsset id="imgAsset18" src="thmb19.swf" embedded="0"/>
		<graphicAsset id="imgAsset19" src="thmb20.swf" embedded="0"/>
		<graphicAsset id="imgAsset20" src="thmb21.swf" embedded="0"/>
		<graphicAsset id="imgAsset21" src="thmb22.swf" embedded="0"/>
		<graphicAsset id="imgAsset22" src="thmb23.swf" embedded="0"/>
		<graphicAsset id="imgAsset23" src="thmb24.swf" embedded="0"/>
		<graphicAsset id="imgAsset24" src="thmb25.swf" embedded="0"/>
		<graphicAsset id="imgAsset25" src="thmb26.swf" embedded="0"/>
		<graphicAsset id="imgAsset26" src="thmb27.swf" embedded="0"/>
		<graphicAsset id="imgAsset27" src="thmb28.swf" embedded="0"/>
		<graphicAsset id="imgAsset28" src="thmb29.swf" embedded="0"/>
		<graphicAsset id="imgAsset29" src="thmb30.swf" embedded="0"/>
		<graphicAsset id="imgAsset30" src="thmb31.swf" embedded="0"/>
		<graphicAsset id="imgAsset31" src="thmb32.swf" embedded="0"/>
		<graphicAsset id="imgAsset32" src="thmb33.swf" embedded="0"/>
		<graphicAsset id="imgAsset33" src="thmb34.swf" embedded="0"/>
		<graphicAsset id="imgAsset34" src="thmb35.swf" embedded="0"/>
	</graphicAssets>
	<backgroundSound soundAssetId="" looping="0" volume="1.0000000"/>
	<narration>
		<audioTracks>
			<audioTrack volume="1.0000000" soundAssetId="sndAsset0">
				<startTimestamp slideIndex="0" stepIndex="0" timeOffset="0.0000000"/>
				<endTimestamp slideIndex="0" stepIndex="0" timeOffset="19.5990000"/>
			</audioTrack>
			<audioTrack volume="1.0000000" soundAssetId="sndAsset1">
				<startTimestamp slideIndex="1" stepIndex="0" timeOffset="0.0000000"/>
				<endTimestamp slideIndex="1" stepIndex="0" timeOffset="75.4680000"/>
			</audioTrack>
			<audioTrack volume="1.0000000" soundAssetId="sndAsset2">
				<startTimestamp slideIndex="2" stepIndex="0" timeOffset="0.0000000"/>
				<endTimestamp slideIndex="2" stepIndex="0" timeOffset="15.6300000"/>
			</audioTrack>
			<audioTrack volume="1.0000000" soundAssetId="sndAsset3">
				<startTimestamp slideIndex="3" stepIndex="0" timeOffset="0.0000000"/>
				<endTimestamp slideIndex="3" stepIndex="0" timeOffset="11.9490000"/>
			</audioTrack>
			<audioTrack volume="1.0000000" soundAssetId="sndAsset4">
				<startTimestamp slideIndex="4" stepIndex="0" timeOffset="0.0000000"/>
				<endTimestamp slideIndex="4" stepIndex="0" timeOffset="16.9139996"/>
			</audioTrack>
			<audioTrack volume="1.0000000" soundAssetId="sndAsset5">
				<startTimestamp slideIndex="5" stepIndex="0" timeOffset="0.0000000"/>
				<endTimestamp slideIndex="5" stepIndex="0" timeOffset="42.0999985"/>
			</audioTrack>
			<audioTrack volume="1.0000000" soundAssetId="sndAsset6">
				<startTimestamp slideIndex="6" stepIndex="0" timeOffset="0.0000000"/>
				<endTimestamp slideIndex="6" stepIndex="0" timeOffset="20.7390000"/>
			</audioTrack>
			<audioTrack volume="1.0000000" soundAssetId="sndAsset7">
				<startTimestamp slideIndex="7" stepIndex="0" timeOffset="0.0000000"/>
				<endTimestamp slideIndex="7" stepIndex="0" timeOffset="18.4370000"/>
			</audioTrack>
			<audioTrack volume="1.0000000" soundAssetId="sndAsset8">
				<startTimestamp slideIndex="8" stepIndex="0" timeOffset="0.0000000"/>
				<endTimestamp slideIndex="8" stepIndex="0" timeOffset="36.5490000"/>
			</audioTrack>
			<audioTrack volume="1.0000000" soundAssetId="sndAsset9">
				<startTimestamp slideIndex="9" stepIndex="0" timeOffset="0.0000000"/>
				<endTimestamp slideIndex="9" stepIndex="0" timeOffset="24.2810000"/>
			</audioTrack>
			<audioTrack volume="1.0000000" soundAssetId="sndAsset10">
				<startTimestamp slideIndex="10" stepIndex="0" timeOffset="0.0000000"/>
				<endTimestamp slideIndex="10" stepIndex="0" timeOffset="20.7350000"/>
			</audioTrack>
			<audioTrack volume="1.0000000" soundAssetId="sndAsset11">
				<startTimestamp slideIndex="11" stepIndex="0" timeOffset="0.0000000"/>
				<endTimestamp slideIndex="11" stepIndex="0" timeOffset="33.5760000"/>
			</audioTrack>
			<audioTrack volume="1.0000000" soundAssetId="sndAsset12">
				<startTimestamp slideIndex="12" stepIndex="0" timeOffset="0.0000000"/>
				<endTimestamp slideIndex="12" stepIndex="0" timeOffset="49.4170000"/>
			</audioTrack>
			<audioTrack volume="1.0000000" soundAssetId="sndAsset13">
				<startTimestamp slideIndex="13" stepIndex="0" timeOffset="0.0000000"/>
				<endTimestamp slideIndex="13" stepIndex="0" timeOffset="37.4690000"/>
			</audioTrack>
			<audioTrack volume="1.0000000" soundAssetId="sndAsset14">
				<startTimestamp slideIndex="14" stepIndex="0" timeOffset="0.0000000"/>
				<endTimestamp slideIndex="14" stepIndex="0" timeOffset="37.5229988"/>
			</audioTrack>
			<audioTrack volume="1.0000000" soundAssetId="sndAsset15">
				<startTimestamp slideIndex="15" stepIndex="0" timeOffset="0.0000000"/>
				<endTimestamp slideIndex="15" stepIndex="0" timeOffset="13.0799999"/>
			</audioTrack>
			<audioTrack volume="1.0000000" soundAssetId="sndAsset16">
				<startTimestamp slideIndex="16" stepIndex="0" timeOffset="0.0000000"/>
				<endTimestamp slideIndex="16" stepIndex="0" timeOffset="24.1860000"/>
			</audioTrack>
			<audioTrack volume="1.0000000" soundAssetId="sndAsset17">
				<startTimestamp slideIndex="17" stepIndex="0" timeOffset="0.0000000"/>
				<endTimestamp slideIndex="17" stepIndex="0" timeOffset="22.5599995"/>
			</audioTrack>
			<audioTrack volume="1.0000000" soundAssetId="sndAsset18">
				<startTimestamp slideIndex="18" stepIndex="0" timeOffset="0.0000000"/>
				<endTimestamp slideIndex="18" stepIndex="0" timeOffset="23.5190000"/>
			</audioTrack>
			<audioTrack volume="1.0000000" soundAssetId="sndAsset19">
				<startTimestamp slideIndex="19" stepIndex="0" timeOffset="0.0000000"/>
				<endTimestamp slideIndex="19" stepIndex="0" timeOffset="24.4560000"/>
			</audioTrack>
			<audioTrack volume="1.0000000" soundAssetId="sndAsset20">
				<startTimestamp slideIndex="20" stepIndex="0" timeOffset="0.0000000"/>
				<endTimestamp slideIndex="20" stepIndex="0" timeOffset="39.5770000"/>
			</audioTrack>
			<audioTrack volume="1.0000000" soundAssetId="sndAsset21">
				<startTimestamp slideIndex="21" stepIndex="0" timeOffset="0.0000000"/>
				<endTimestamp slideIndex="21" stepIndex="0" timeOffset="14.1660000"/>
			</audioTrack>
			<audioTrack volume="1.0000000" soundAssetId="sndAsset22">
				<startTimestamp slideIndex="22" stepIndex="0" timeOffset="0.0000000"/>
				<endTimestamp slideIndex="22" stepIndex="0" timeOffset="27.7090000"/>
			</audioTrack>
			<audioTrack volume="1.0000000" soundAssetId="sndAsset23">
				<startTimestamp slideIndex="23" stepIndex="0" timeOffset="0.0000000"/>
				<endTimestamp slideIndex="23" stepIndex="0" timeOffset="18.2270000"/>
			</audioTrack>
			<audioTrack volume="1.0000000" soundAssetId="sndAsset24">
				<startTimestamp slideIndex="24" stepIndex="0" timeOffset="0.0000000"/>
				<endTimestamp slideIndex="24" stepIndex="0" timeOffset="28.8700000"/>
			</audioTrack>
			<audioTrack volume="1.0000000" soundAssetId="sndAsset25">
				<startTimestamp slideIndex="25" stepIndex="0" timeOffset="0.0000000"/>
				<endTimestamp slideIndex="25" stepIndex="0" timeOffset="72.1620000"/>
			</audioTrack>
			<audioTrack volume="1.0000000" soundAssetId="sndAsset26">
				<startTimestamp slideIndex="26" stepIndex="0" timeOffset="0.0000000"/>
				<endTimestamp slideIndex="26" stepIndex="0" timeOffset="99.8529968"/>
			</audioTrack>
			<audioTrack volume="1.0000000" soundAssetId="sndAsset27">
				<startTimestamp slideIndex="27" stepIndex="0" timeOffset="0.0000000"/>
				<endTimestamp slideIndex="27" stepIndex="0" timeOffset="48.3050000"/>
			</audioTrack>
			<audioTrack volume="1.0000000" soundAssetId="sndAsset28">
				<startTimestamp slideIndex="28" stepIndex="0" timeOffset="0.0000000"/>
				<endTimestamp slideIndex="28" stepIndex="0" timeOffset="59.8300000"/>
			</audioTrack>
			<audioTrack volume="1.0000000" soundAssetId="sndAsset29">
				<startTimestamp slideIndex="29" stepIndex="0" timeOffset="0.0000000"/>
				<endTimestamp slideIndex="29" stepIndex="0" timeOffset="21.3390000"/>
			</audioTrack>
			<audioTrack volume="1.0000000" soundAssetId="sndAsset30">
				<startTimestamp slideIndex="30" stepIndex="0" timeOffset="0.0000000"/>
				<endTimestamp slideIndex="30" stepIndex="0" timeOffset="36.7660000"/>
			</audioTrack>
			<audioTrack volume="1.0000000" soundAssetId="sndAsset31">
				<startTimestamp slideIndex="31" stepIndex="0" timeOffset="0.0000000"/>
				<endTimestamp slideIndex="31" stepIndex="0" timeOffset="60.0370000"/>
			</audioTrack>
			<audioTrack volume="1.0000000" soundAssetId="sndAsset32">
				<startTimestamp slideIndex="32" stepIndex="0" timeOffset="0.0000000"/>
				<endTimestamp slideIndex="32" stepIndex="0" timeOffset="30.2960000"/>
			</audioTrack>
			<audioTrack volume="1.0000000" soundAssetId="sndAsset33">
				<startTimestamp slideIndex="33" stepIndex="0" timeOffset="0.0000000"/>
				<endTimestamp slideIndex="33" stepIndex="0" timeOffset="32.5099983"/>
			</audioTrack>
			<audioTrack volume="1.0000000" soundAssetId="sndAsset34">
				<startTimestamp slideIndex="34" stepIndex="0" timeOffset="0.0000000"/>
				<endTimestamp slideIndex="34" stepIndex="0" timeOffset="41.7400000"/>
			</audioTrack>
		</audioTracks>
	</narration>
	<settings>
		<navigation>
			<keyboard enabled="1">
				<actions>
					<action name="playPause">
						<shortcut code="32" control="0" shift="0"/>
					</action>
					<action name="nextSlide">
						<shortcut code="34" control="0" shift="0"/>
					</action>
					<action name="previousSlide">
						<shortcut code="33" control="0" shift="0"/>
					</action>
					<action name="nextStep">
						<shortcut code="13" control="0" shift="0"/>
					</action>
					<action name="previousStep">
						<shortcut code="13" control="0" shift="1"/>
					</action>
					<action name="firstSlide">
						<shortcut code="36" control="1" shift="0"/>
					</action>
					<action name="lastSlide">
						<shortcut code="35" control="1" shift="0"/>
					</action>
					<action name="lastViewedSlide">
						<shortcut code="8" control="0" shift="0"/>
					</action>
					<action name="slideStart">
						<shortcut code="36" control="0" shift="0"/>
					</action>
					<action name="slideEnd">
						<shortcut code="35" control="0" shift="0"/>
					</action>
					<action name="seekForward">
						<shortcut code="39" control="0" shift="0"/>
					</action>
					<action name="seekBackward">
						<shortcut code="37" control="0" shift="0"/>
					</action>
					<action name="volumeUp">
						<shortcut code="38" control="0" shift="0"/>
					</action>
					<action name="volumeDown">
						<shortcut code="40" control="0" shift="0"/>
					</action>
					<action name="toggleFullscreen">
						<shortcut code="70" control="1" shift="0"/>
					</action>
				</actions>
			</keyboard>
			<mouse enabled="1" target="step"/>
			<gesture zoom="1"/>
		</navigation>
		<skin>
			<colorSettings>
				<color id="button.content.normal">#FFFFFF</color>
				<color id="button.content.over">#FFFFFF</color>
				<color id="button.face.normal">#777777</color>
				<color id="button.face.over">#575757</color>
				<color id="companyLogo.background">#FFFFFF</color>
				<color id="hyperlink">#097CE7</color>
				<color id="listItem.face.over">#E8E8E8</color>
				<color id="listItem.face.pressed">#6E6E6E</color>
				<color id="listItem.label.over">#000000</color>
				<color id="listItem.label.pressed">#FFFFFF</color>
				<color id="listItem.label.visited">#A1A1A1</color>
				<color id="page.background">#8A8A8A</color>
				<color id="panel.background">#F7F7F7</color>
				<color id="panel.text">#323232</color>
				<color id="player.background">#D4D4D4</color>
				<color id="popup.background">#FFFFFF</color>
				<color id="progress.background">#6E6E6E</color>
				<color id="progress.loading">#D0D0D0</color>
				<color id="progress.playback">#A1A1A1</color>
				<color id="text">#4D4D4D</color>
			</colorSettings>
			<controlPanelSettings>
				<visible>true</visible>
				<showOutline>false</showOutline>
				<showPlayPause>true</showPlayPause>
				<showRewind>true</showRewind>
				<showVolumeControl>true</showVolumeControl>
				<showCCButton>false</showCCButton>
				<showPrevButton>true</showPrevButton>
				<showNextButton>true</showNextButton>
				<showSlideOnlyButton>true</showSlideOnlyButton>
				<progressBar>
					<visible>true</visible>
					<enabled>true</enabled>
					<showLabels>true</showLabels>
					<mode>slideTimeline</mode>
				</progressBar>
				<navigationMode>bySlides</navigationMode>
			</controlPanelSettings>
			<titlePanelSettings>
				<showLogo>false</showLogo>
				<visible>true</visible>
				<buttons>
					<button type="attachments" visible="false"/>
					<button type="presenterInfo" visible="false"/>
					<button type="markerTools" visible="true"/>
					<button type="notes" visible="false"/>
					<button type="outline" visible="false"/>
				</buttons>
			</titlePanelSettings>
			<outlinePanelSettings>
				<numberEntries>true</numberEntries>
				<highlightViewedEntries>true</highlightViewedEntries>
				<thumbnails>true</thumbnails>
				<search>true</search>
				<multilevel>true</multilevel>
			</outlinePanelSettings>
			<sidePanelSettings>
				<showAtLeft>true</showAtLeft>
				<showLogo>false</showLogo>
				<showPresenterInfo>true</showPresenterInfo>
				<showPresenterVideo>false</showPresenterVideo>
				<visible>true</visible>
				<tabsPanel>
					<showOutline>true</showOutline>
					<showNotes>false</showNotes>
				</tabsPanel>
			</sidePanelSettings>
		</skin>
		<appearance fullScreen="1" showSlidePreloader="1"/>
		<playback autoStart="1" syncWithVideoNarration="1" enableVideoControl="1" resumePresentationPlayback="never"/>
	</settings>
	<slides embedded="0">
		<slide index="0" title="EUS for portal hypertension and varix management" titleNormalized="eus for portal hypertension and varix management" src="slide1.swf" size="123338" advanceOnTime="1" framesCount="1" hasEmbeddedFlashClip="0" hidden="0" level="0" advanceOnClick="1" thumbnailAssetId="imgAsset0" presenterIndex="0">
			<sounds/>
			<videos/>
			<transitionEffect name="" duration="0.0000000" soundId="" looped="0"/>
			<soundCommands/>
			<videoCommands/>
			<animationSteps>
				<step start="0" end="0" playTime="0.0010000" pauseTime="19.5980009"/>
			</animationSteps>
			<notes>Endoscopic ultrasound (EUS) is emerging as a useful diagnostic and therapeutic tool for the evaluation and management of gastroesophageal varices </notes>
			<notesNormalized>endoscopic ultrasound (eus) is emerging as a useful diagnostic and therapeutic tool for the evaluation and management of gastroesophageal varices</notesNormalized>
			<notesHtml>&lt;p&gt;&lt;font size="12"&gt;Endoscopic ultrasound (EUS) is emerging as a useful diagnostic and therapeutic tool for the evaluation and management of gastroesophageal varices &lt;/font&gt;&lt;/p&gt;</notesHtml>
			<text>EUS for portal hypertension 
and varix management
THAWEE Ratanachu-EK, MD 
Digestive Endoscopy Center
Rajavithi Hospital, Bangkok, THAILAND
EUS Summit 2018, 6-7 October, AMC, Seoul, Korea</text>
		</slide>
		<slide index="1" title="Article" titleNormalized="article" src="slide2.swf" size="95614" advanceOnTime="1" framesCount="1" hasEmbeddedFlashClip="0" hidden="0" level="0" advanceOnClick="1" thumbnailAssetId="imgAsset1" presenterIndex="0">
			<sounds/>
			<videos/>
			<transitionEffect name="" duration="0.0000000" soundId="" looped="0"/>
			<soundCommands/>
			<videoCommands/>
			<animationSteps>
				<step start="0" end="0" playTime="0.0010000" pauseTime="75.4670023"/>
			</animationSteps>
			<notes/>
			<notesNormalized/>
			<notesHtml/>
		</slide>
		<slide index="2" title="" titleNormalized="" src="slide3.swf" size="373327" advanceOnTime="1" framesCount="379" hasEmbeddedFlashClip="0" hidden="0" level="0" advanceOnClick="1" thumbnailAssetId="imgAsset2" presenterIndex="0">
			<sounds/>
			<videos>
				<video id="video0" videoClipId="ispring.resources_f0d5e70.spr0_6138686" slides="1" repeat="1" volume="0.8000000" posterFrameId="ispring.resources_f0d5e70.spr2_6138686" playFullScreen="0" hideWhenNotPlaying="0" rewindAfterPlaying="0"/>
			</videos>
			<transitionEffect name="" duration="0.0000000" soundId="" looped="0"/>
			<soundCommands/>
			<videoCommands>
				<playVideo frameIndex="0" videoId="video0" startPos="0.0000000"/>
			</videoCommands>
			<animationSteps>
				<step start="0" end="378" playTime="15.6300001" pauseTime="0.0000000"/>
			</animationSteps>
			<notes/>
			<notesNormalized/>
			<notesHtml/>
		</slide>
		<slide index="3" title="EUS for portal hypertension and varix management" titleNormalized="eus for portal hypertension and varix management" src="slide4.swf" size="1425" advanceOnTime="1" framesCount="1" hasEmbeddedFlashClip="0" hidden="0" level="0" advanceOnClick="1" thumbnailAssetId="imgAsset3" presenterIndex="0">
			<sounds/>
			<videos/>
			<transitionEffect name="" duration="0.0000000" soundId="" looped="0"/>
			<soundCommands/>
			<videoCommands/>
			<animationSteps>
				<step start="0" end="0" playTime="0.0010000" pauseTime="11.9480004"/>
			</animationSteps>
			<notes>Next 20 min I’ll summarize the current role of EUS for PHT emphasize on EG varices and management esp.new  immerging intervention of GV.</notes>
			<notesNormalized>next 20 min i’ll summarize the current role of eus for pht emphasize on eg varices and management esp.new immerging intervention of gv.</notesNormalized>
			<notesHtml>&lt;p&gt;&lt;font size="12"&gt;Next 20 min I’ll summarize the current role of EUS for PHT emphasize on EG varices and management esp.new  immerging intervention of GV.&lt;/font&gt;&lt;/p&gt;</notesHtml>
			<text>EUS for portal hypertension 
and varix management
PHT: Varices and Collateral pathways
Role of EUS
Immerging new intervention
</text>
		</slide>
		<slide index="4" title="Portal Hypertension: Variceal Bleeding" titleNormalized="portal hypertension: variceal bleeding" src="slide5.swf" size="346726" advanceOnTime="1" framesCount="409" hasEmbeddedFlashClip="0" hidden="0" level="0" advanceOnClick="1" thumbnailAssetId="imgAsset4" presenterIndex="0">
			<sounds/>
			<videos>
				<video id="video1" videoClipId="ispring.resources_11234540.spr0_6146096" slides="1" repeat="1" volume="0.8000000" posterFrameId="ispring.resources_11234540.spr2_6146096" playFullScreen="0" hideWhenNotPlaying="0" rewindAfterPlaying="0"/>
			</videos>
			<transitionEffect name="" duration="0.0000000" soundId="" looped="0"/>
			<soundCommands/>
			<videoCommands>
				<playVideo frameIndex="0" videoId="video1" startPos="0.0000000"/>
			</videoCommands>
			<animationSteps>
				<step start="0" end="408" playTime="16.9139996" pauseTime="0.0000000"/>
			</animationSteps>
			<notes>Variceal bleeding  is one of the most serious event and cause of death in patients with portal hypertension.</notes>
			<notesNormalized>variceal bleeding is one of the most serious event and cause of death in patients with portal hypertension.</notesNormalized>
			<notesHtml>&lt;p&gt;&lt;font size="12"&gt;Variceal bleeding  is one of the most serious event and cause of death in patients with portal hypertension.&lt;/font&gt;&lt;/p&gt;</notesHtml>
		</slide>
		<slide index="5" title="Clinical management of acute variceal bleeding" titleNormalized="clinical management of acute variceal bleeding" src="slide6.swf" size="3999" advanceOnTime="1" framesCount="1" hasEmbeddedFlashClip="0" hidden="0" level="0" advanceOnClick="1" thumbnailAssetId="imgAsset5" presenterIndex="0">
			<sounds/>
			<videos/>
			<transitionEffect name="" duration="0.0000000" soundId="" looped="0"/>
			<soundCommands/>
			<videoCommands/>
			<animationSteps>
				<step start="0" end="0" playTime="0.0010000" pauseTime="42.0989985"/>
			</animationSteps>
			<notes>More than a decade, The efficient multi-step management of active bleeding have significantly improved the outcomes. Endoscopy plays the important role both diagnosis and treatment.</notes>
			<notesNormalized>more than a decade, the efficient multi-step management of active bleeding have significantly improved the outcomes. endoscopy plays the important role both diagnosis and treatment.</notesNormalized>
			<notesHtml>&lt;p&gt;&lt;font size="12"&gt;More than a decade, The efficient multi-step management of active bleeding have significantly improved the outcomes. Endoscopy plays the important role both diagnosis and treatment.&lt;/font&gt;&lt;/p&gt;</notesHtml>
			<text>de Franchis R. J Hepatol 2015;63:743-752

Clinical management of acute variceal bleeding
Suspected variceal bleeding
Resuscitation/ICU, antibiotic, blood component,…
Early vasoactive drug administration
(Somatostation/Octreotide/Trelipresssin)
Endoscopy
(Diagnosis/Therapeutic)
Control active bleeding
(Banding,EIS-EV/Glue-GV) 
Re-bleeding
Schedule for
endoscopic 
eradication
Rescued with BRTO, TIPS/Surgery
Optional: SEMS* (EV)
Balloon intubation* (SB for EV, Linton-Nachlas for GV)
Hemospray* (EV,GV) 
 
X
* only for temporary therapy
 Garcia-Tsao G, et al. Am J Gastroenterol 2007;102:2086–2102 
Ibrahim M, et al. United European Gastroenterology Journal 2015,3:277–283</text>
		</slide>
		<slide index="6" title="EGVs: Diagnostic EGD" titleNormalized="egvs: diagnostic egd" src="slide7.swf" size="55078" advanceOnTime="1" framesCount="1" hasEmbeddedFlashClip="0" hidden="0" level="0" advanceOnClick="1" thumbnailAssetId="imgAsset6" presenterIndex="0">
			<sounds/>
			<videos/>
			<transitionEffect name="" duration="0.0000000" soundId="" looped="0"/>
			<soundCommands/>
			<videoCommands/>
			<animationSteps>
				<step start="0" end="0" playTime="0.0010000" pauseTime="20.7389998"/>
			</animationSteps>
			<notes/>
			<notesNormalized/>
			<notesHtml/>
			<text>EGVs: Diagnostic EGD
White nipple sign
RWM: Cherry red spots,CRS
 Hematocystic spots
Index bleeder
Predicted bleeding risk</text>
		</slide>
		<slide index="7" title="Esophago-gastric varices: Endotherapy" titleNormalized="esophago-gastric varices: endotherapy" src="slide8.swf" size="2687" advanceOnTime="1" framesCount="1" hasEmbeddedFlashClip="0" hidden="0" level="0" advanceOnClick="1" thumbnailAssetId="imgAsset7" presenterIndex="0">
			<sounds/>
			<videos/>
			<transitionEffect name="" duration="0.0000000" soundId="" looped="0"/>
			<soundCommands/>
			<videoCommands/>
			<animationSteps>
				<step start="0" end="0" playTime="0.0010000" pauseTime="18.4390005"/>
			</animationSteps>
			<notes>Endoscopy is the important modalities  treatment for EGVs, such as endoscopic injection sclerotherapy (EIS), endoscopic variceal ligation (EVL) mainly for EV and  cyanoacrylate glue (CYA) injection for GV under conventional endoscopy. </notes>
			<notesNormalized>endoscopy is the important modalities treatment for egvs, such as endoscopic injection sclerotherapy (eis), endoscopic variceal ligation (evl) mainly for ev and cyanoacrylate glue (cya) injection for gv under conventional endoscopy.</notesNormalized>
			<notesHtml>&lt;p&gt;&lt;font size="12"&gt;Endoscopy is the important modalities  treatment for EGVs, such as endoscopic injection sclerotherapy (EIS), endoscopic variceal ligation (EVL) mainly for EV and  cyanoacrylate glue (CYA) injection for GV under conventional endoscopy. &lt;/font&gt;&lt;/p&gt;</notesHtml>
			<text>Esophago-gastric varices: Endotherapy
Esophageal varices Gastric varices
Primary prophylaxis
 Banding
Control bleeding
 Banding
 Injection sclerotherapy
 optional: Glue injection#/SB intubation*
Secondary prophylaxis
 Banding
 Injection sclerotherapy
 

Primary prophylaxis
 Questionable#
Control bleeding
 Glue injection (GOV1/2,IGV)
 Sclerotherapy/BRTO
 Banding (GOV1) 
 optional: SB intubation (GOV1)#
Secondary prophylaxis
 Glue injection
 

TIPS (IR)/ Surgery
* only for briding therapy
# for rescue therapy/post band induced ulcer bleeding
# Garcia-Pagan JC, et al.CGH2014;12:919-928</text>
		</slide>
		<slide index="8" title="EGVs: Improved outcome?" titleNormalized="egvs: improved outcome?" src="slide9.swf" size="2308" advanceOnTime="1" framesCount="1" hasEmbeddedFlashClip="0" hidden="0" level="0" advanceOnClick="1" thumbnailAssetId="imgAsset8" presenterIndex="0">
			<sounds/>
			<videos/>
			<transitionEffect name="" duration="0.0000000" soundId="" looped="0"/>
			<soundCommands/>
			<videoCommands/>
			<animationSteps>
				<step start="0" end="0" playTime="0.0010000" pauseTime="36.5489992"/>
			</animationSteps>
			<notes>Although well control  active bleeding, anyway let still a certain number of uncontrolled and recurrent bleeding 10-20% and serious embolism from glue injection.</notes>
			<notesNormalized>although well control active bleeding, anyway let still a certain number of uncontrolled and recurrent bleeding 10-20% and serious embolism from glue injection.</notesNormalized>
			<notesHtml>&lt;p&gt;&lt;font size="12"&gt;Although well control  active bleeding, anyway let still a certain number of uncontrolled and recurrent bleeding 10-20% and serious embolism from glue injection.&lt;/font&gt;&lt;/p&gt;</notesHtml>
			<text>EGVs: Improved outcome?
Esophageal varices Gastric varices (GOV2/IGV1)
Initial hemostasis: 83%-100%
Re-bleeding: 8%-18%
Embolism 2.1%

MARTINEZ-GONZALEZ J, et al. Rev. esp. enferm. dig. [online]. 2015,107, pp.501-508. 
Cipolletta L, et al. Gastrointest Endosc. 1998; 47:400-3
Lee MS, et al. Gastrointest Endosc. 2002; 56:83-8.
Al-Bawardy B, et al. J Clin gastroenterol 2016;50:4580462 
Initial hemostasis:&gt; 90% 
Un-controlled*/ Re-bleeding: 10-20%
Stricture (EIS) 11%

 *An elevated HVPG &gt;20 mmHg 
(measured within 24 hours of presentation)
 Garcia-Tsao G, et al. Am J Gastroenterol 2007;102:2086–2102 
EVL&gt;EIS Glue</text>
		</slide>
		<slide index="9" title="EGVs: Tip the Iceberg" titleNormalized="egvs: tip the iceberg" src="slide10.swf" size="446343" advanceOnTime="1" framesCount="585" hasEmbeddedFlashClip="0" hidden="0" level="0" advanceOnClick="1" thumbnailAssetId="imgAsset9" presenterIndex="0">
			<sounds/>
			<videos>
				<video id="video2" videoClipId="ispring.resources_189479d0.spr0_6157219" slides="1" repeat="1" volume="0.8000000" posterFrameId="ispring.resources_189479d0.spr2_6157219" playFullScreen="0" hideWhenNotPlaying="0" rewindAfterPlaying="0"/>
			</videos>
			<transitionEffect name="" duration="0.0000000" soundId="" looped="0"/>
			<soundCommands/>
			<videoCommands>
				<playVideo frameIndex="0" videoId="video2" startPos="0.0000000"/>
			</videoCommands>
			<animationSteps>
				<step start="0" end="584" playTime="24.3299999" pauseTime="0.0000000"/>
			</animationSteps>
			<notes>However, these approaches are performed only varices seen in endoscopy
But beneath or outside the wall of the esophagus and stomach cannot be observed directly liked ICEberg. </notes>
			<notesNormalized>however, these approaches are performed only varices seen in endoscopy
but beneath or outside the wall of the esophagus and stomach cannot be observed directly liked iceberg.</notesNormalized>
			<notesHtml>&lt;p&gt;&lt;font size="12"&gt;However, these approaches are performed only varices seen in endoscopy&lt;/font&gt;&lt;/p&gt;&lt;p&gt;&lt;font size="12"&gt;But beneath or outside the wall of the esophagus and stomach cannot be observed directly liked ICEberg. &lt;/font&gt;&lt;/p&gt;</notesHtml>
		</slide>
		<slide index="10" title="EGVs: Unseen" titleNormalized="egvs: unseen" src="slide11.swf" size="29581" advanceOnTime="1" framesCount="1" hasEmbeddedFlashClip="0" hidden="0" level="0" advanceOnClick="1" thumbnailAssetId="imgAsset10" presenterIndex="0">
			<sounds/>
			<videos/>
			<transitionEffect name="" duration="0.0000000" soundId="" looped="0"/>
			<soundCommands/>
			<videoCommands/>
			<animationSteps>
				<step start="0" end="0" playTime="0.0010000" pauseTime="20.7389998"/>
			</animationSteps>
			<notes>This unseen deeper part is very important to determine complete control bleeder and predict recurrent.
So this the majority of varices beneath will be explored later on </notes>
			<notesNormalized>this unseen deeper part is very important to determine complete control bleeder and predict recurrent.
so this the majority of varices beneath will be explored later on</notesNormalized>
			<notesHtml>&lt;p&gt;&lt;font size="12"&gt;This unseen deeper part is very important to determine complete control bleeder and predict recurrent.&lt;/font&gt;&lt;/p&gt;&lt;p&gt;&lt;font size="12"&gt;So this the majority of varices beneath will be explored later on &lt;/font&gt;&lt;/p&gt;</notesHtml>
			<text>EGVs: Unseen
Courtesy: iceberg picture from istockphoto.com
Irisawa A, et al. Gastrointest Endosc 1999;50:374-380
 drawing picture: Dr.Tanyaporn Chantarojanasiri</text>
		</slide>
		<slide index="11" title="EGVs: EUS-See more," titleNormalized="egvs: eus-see more," src="slide12.swf" size="417558" advanceOnTime="1" framesCount="809" hasEmbeddedFlashClip="0" hidden="0" level="0" advanceOnClick="1" thumbnailAssetId="imgAsset11" presenterIndex="0">
			<sounds/>
			<videos>
				<video id="video3" videoClipId="ispring.resources_18765350.spr0_6171305" slides="1" repeat="1" volume="0.8000000" posterFrameId="ispring.resources_18765350.spr2_6171305" playFullScreen="0" hideWhenNotPlaying="0" rewindAfterPlaying="0"/>
			</videos>
			<transitionEffect name="" duration="0.0000000" soundId="" looped="0"/>
			<soundCommands/>
			<videoCommands>
				<playVideo frameIndex="0" videoId="video3" startPos="0.0000000"/>
			</videoCommands>
			<animationSteps>
				<step start="0" end="808" playTime="33.5760002" pauseTime="0.0000000"/>
			</animationSteps>
			<notes/>
			<notesNormalized/>
			<notesHtml/>
		</slide>
		<slide index="12" title="Varices &amp; Collateral pathways" titleNormalized="varices &amp; collateral pathways" src="slide13.swf" size="10825" advanceOnTime="1" framesCount="1" hasEmbeddedFlashClip="0" hidden="0" level="0" advanceOnClick="1" thumbnailAssetId="imgAsset12" presenterIndex="0">
			<sounds/>
			<videos/>
			<transitionEffect name="" duration="0.0000000" soundId="" looped="0"/>
			<soundCommands/>
			<videoCommands/>
			<animationSteps>
				<step start="0" end="0" playTime="0.0010000" pauseTime="49.4189982"/>
			</animationSteps>
			<notes>Back to understand the collateral pathway of varices formation that is very important for varices management in term of how to decrease rebleeding the mortality or even control in active bleeding.</notes>
			<notesNormalized>back to understand the collateral pathway of varices formation that is very important for varices management in term of how to decrease rebleeding the mortality or even control in active bleeding.</notesNormalized>
			<notesHtml>&lt;p&gt;&lt;font size="12"&gt;Back to understand the collateral pathway of varices formation that is very important for varices management in term of how to decrease rebleeding the mortality or even control in active bleeding.&lt;/font&gt;&lt;/p&gt;</notesHtml>
			<text>LRV
Azygos vein
Peri-
ECVs
Perforating
 vein
Varix
Dilated 
SC vs
Dilated SE vs 
(RWM,CRS)
LGV
Para-
ECV
IVC
PV
SV
SMV
Gastro-renal shunt
SGV
PGV
GV (IGV1)
GV (GOV2)
GV (GOV1)
Varices &amp; Collateral pathways
HAZV
Spleen
Liver
EV
EV
IGV2
Gastric wall
Gastric wall
Esophageal 
 wall</text>
		</slide>
		<slide index="13" title="Varices &amp; Collateral pathways: GV" titleNormalized="varices &amp; collateral pathways: gv" src="slide14.swf" size="59221" advanceOnTime="1" framesCount="1" hasEmbeddedFlashClip="0" hidden="0" level="0" advanceOnClick="1" thumbnailAssetId="imgAsset13" presenterIndex="0">
			<sounds/>
			<videos/>
			<transitionEffect name="" duration="0.0000000" soundId="" looped="0"/>
			<soundCommands/>
			<videoCommands/>
			<animationSteps>
				<step start="0" end="0" playTime="0.0010000" pauseTime="37.4690012"/>
			</animationSteps>
			<notes/>
			<notesNormalized/>
			<notesHtml/>
			<text>drawing picture by Dr.Tanyaporn Chantarojanasiri
Mehta G, Abraldes JG, Bosch J. Gut 2010;59:701-705. 
Charbel YAZBECK, MD. NDS University Hospital, USEK
EV
GOV1
LGV
PV
SV
IGV2
RV
SMV
GOV2/IGV1
LGV
PGV
SGV
GRS
Varices &amp; Collateral pathways: GV</text>
		</slide>
		<slide index="14" title="EUS for EGVs: See more" titleNormalized="eus for egvs: see more" src="slide15.swf" size="399205" advanceOnTime="1" framesCount="903" hasEmbeddedFlashClip="0" hidden="0" level="0" advanceOnClick="1" thumbnailAssetId="imgAsset14" presenterIndex="0">
			<sounds/>
			<videos>
				<video id="video4" videoClipId="ispring.resources_18abebc0.spr0_6187046" slides="1" repeat="1" volume="0.8000000" posterFrameId="ispring.resources_18abebc0.spr2_6187046" playFullScreen="0" hideWhenNotPlaying="0" rewindAfterPlaying="0"/>
			</videos>
			<transitionEffect name="" duration="0.0000000" soundId="" looped="0"/>
			<soundCommands/>
			<videoCommands>
				<playVideo frameIndex="0" videoId="video4" startPos="0.0000000"/>
			</videoCommands>
			<animationSteps>
				<step start="0" end="902" playTime="37.5229988" pauseTime="0.0000000"/>
			</animationSteps>
			<notes/>
			<notesNormalized/>
			<notesHtml/>
		</slide>
		<slide index="15" title="EUS for EGVs: Do more" titleNormalized="eus for egvs: do more" src="slide16.swf" size="39445" advanceOnTime="1" framesCount="1" hasEmbeddedFlashClip="0" hidden="0" level="0" advanceOnClick="1" thumbnailAssetId="imgAsset15" presenterIndex="0">
			<sounds/>
			<videos/>
			<transitionEffect name="" duration="0.0000000" soundId="" looped="0"/>
			<soundCommands/>
			<videoCommands/>
			<animationSteps>
				<step start="0" end="0" playTime="0.0010000" pauseTime="13.0789999"/>
			</animationSteps>
			<notes/>
			<notesNormalized/>
			<notesHtml/>
			<text>EUS for EGVs: Do more
Diagnosis*
Visualization and evaluation of EGVs (peri-,paravariceal, perforating v, LGVs
 Visualize of portal and azygos system
 Flow direction (inflow vs out flow)
Measured portal pressure gradient (PPG) and measure vein cut surface area (CSA) by digitalized image
*Wang A-J, et al. Endoscopic Ultrasound. 2016;5:218-224.
Huang JY, et al. Gastrointest Endosc 2017;85:996-1001</text>
		</slide>
		<slide index="16" title="Endoscopic Ultrasound-Guided Portal Pressure Measurement" titleNormalized="endoscopic ultrasound-guided portal pressure measurement" src="slide17.swf" size="39602" advanceOnTime="1" framesCount="1" hasEmbeddedFlashClip="0" hidden="0" level="0" advanceOnClick="1" thumbnailAssetId="imgAsset16" presenterIndex="0">
			<sounds/>
			<videos/>
			<transitionEffect name="" duration="0.0000000" soundId="" looped="0"/>
			<soundCommands/>
			<videoCommands/>
			<animationSteps>
				<step start="0" end="0" playTime="0.0010000" pauseTime="24.1890005"/>
			</animationSteps>
			<notes>Ken chang group demonstrated feasibility of  eus guide technique to measure PPG and they found excellent correlation with some clinical parameter of PH. </notes>
			<notesNormalized>ken chang group demonstrated feasibility of eus guide technique to measure ppg and they found excellent correlation with some clinical parameter of ph.</notesNormalized>
			<notesHtml>&lt;p&gt;&lt;font size="12"&gt;Ken chang group demonstrated feasibility of  eus guide technique to measure PPG and they found excellent correlation with some clinical parameter of PH. &lt;/font&gt;&lt;/p&gt;</notesHtml>
			<text>Endoscopic Ultrasound-Guided Portal Pressure Measurement 
Huang JY, et al. Gastrointest Endosc 2017;85:996-1001
PPG measurement (PPGM) accurately reflects the degree of PH

 


Target: Portal vein and Hepatic vein (or inferior vena cava) (via transgastric/transduodenal) 

 


First human trial: 28 patients underwent EUS-PPGM with 100% technical success and no complications. 

 


PPG ranged from 1.5–19mmHg and had excellent correlation with clinical parameters of PH
 : presence of varices (p=0.0002), 
 : PH gastropathy (p=0.007) 
 : thrombocytopenia (p=0.036)
 : cirrhosis (p=0.005).
Compact manometer</text>
		</slide>
		<slide index="17" title="EUS for EGVs: Use more" titleNormalized="eus for egvs: use more" src="slide18.swf" size="1915" advanceOnTime="1" framesCount="1" hasEmbeddedFlashClip="0" hidden="0" level="0" advanceOnClick="1" thumbnailAssetId="imgAsset17" presenterIndex="0">
			<sounds/>
			<videos/>
			<transitionEffect name="" duration="0.0000000" soundId="" looped="0"/>
			<soundCommands/>
			<videoCommands/>
			<animationSteps>
				<step start="0" end="0" playTime="0.0010000" pauseTime="22.5589995"/>
			</animationSteps>
			<notes> what’s benefit for seeing more, number 1, number 2 and more impostantly number 3</notes>
			<notesNormalized>what’s benefit for seeing more, number 1, number 2 and more impostantly number 3</notesNormalized>
			<notesHtml>&lt;p&gt;&lt;font size="12"&gt; what’s benefit for seeing more, number 1, number 2 and more impostantly number 3&lt;/font&gt;&lt;/p&gt;</notesHtml>
			<text>EUS for EGVs: Use more
Management
Predict risk of bleeding, recurrence, re-bleeding
Assessment of pharmacological effect of drugs on PH
Predictor outcomes of EGVs
EUS guided therapy:
 sclerotherapy/ glue/ coil /,…
 Intrahepatic portosystemic shunt 
Wang A-J, et al. Endoscopic Ultrasound. 2016;5:218-224.
“Clinical application”</text>
		</slide>
		<slide index="18" title="EUS for EGVs: See more, more prediction" titleNormalized="eus for egvs: see more, more prediction" src="slide19.swf" size="2741" advanceOnTime="1" framesCount="1" hasEmbeddedFlashClip="0" hidden="0" level="0" advanceOnClick="1" thumbnailAssetId="imgAsset18" presenterIndex="0">
			<sounds/>
			<videos/>
			<transitionEffect name="" duration="0.0000000" soundId="" looped="0"/>
			<soundCommands/>
			<videoCommands/>
			<animationSteps>
				<step start="0" end="0" playTime="0.0010000" pauseTime="23.5190005"/>
			</animationSteps>
			<notes/>
			<notesNormalized/>
			<notesHtml/>
			<text>EUS for EGVs: See more, more prediction
Predict risk of variceal rupture 

Faigel DO, et al. Gastrointest Endosc. 2000; 52:455-62.
97% prior bleeding (+ Paraesophageal varices) vs 3% in control (OR3.1) 
Miller L, et al. Am J Gastroenterol. 2003; 98:454-9.
Measure variceal cut surface area (CSA) by digitalized image: 
76 fold increase: Sq.cm
Predict risk of re-bleeding 

Severe periesophageal collateral veins and large perforating veins.
Predict risk of recurrence
Irisawa A, et al. Gastrointest Endosc. 2001; 53:77-84.
Sato T, et al. Hepatol Res. 2009; 39:126-33.
Perforating veins: inflowing direction and more cardia intramural veins.
Hino S, et al. Endoscopy. 2001; 33:869-72.
LGV: High hepatofugal flow (&gt;12 cm/s), dominance of anterior branch
Kuramochi A, Hino S, Gastroenterol. 2007; 42:219-24
Irisawa A, et al. Gastrointest Endosc. 1999; 50:374-380.
Main ref. Wang A-J, et al. Endoscopic Ultrasound. 2016;5:218-224.
EV</text>
		</slide>
		<slide index="19" title="EUS for EGVs: See more, treat more" titleNormalized="eus for egvs: see more, treat more" src="slide20.swf" size="2299" advanceOnTime="1" framesCount="1" hasEmbeddedFlashClip="0" hidden="0" level="0" advanceOnClick="1" thumbnailAssetId="imgAsset19" presenterIndex="0">
			<sounds/>
			<videos/>
			<transitionEffect name="" duration="0.0000000" soundId="" looped="0"/>
			<soundCommands/>
			<videoCommands/>
			<animationSteps>
				<step start="0" end="0" playTime="0.0010000" pauseTime="24.4589991"/>
			</animationSteps>
			<notes/>
			<notesNormalized/>
			<notesHtml/>
			<text>Efficacy of pharmacotherapy
Liao WC, et al. J Gastroenterol. 2015; 50:342-9.
EUS for EGVs: See more, treat more
Measure: Azygos blood flow 
A marked decrease after 1, 5, and 10 min bolus injections 
of terlipressin and somatostatin.
Lee YT, et al. Gastrointest Endosc. 1999; 50:47-52.
: Volumetric change of paraesophageal varices (related with risk of recurrence)
 Guided therapy
Lahoti S, et al. Gastrointest Endosc 2000;51:331-333
de Paulo GA, et al. Gastrointest Endosc. 2006; 63:396-402.

Targeting the perforating veins (EV): Good result and less recurrence
EV</text>
		</slide>
		<slide index="20" title="Gastric varices: Endotherapy" titleNormalized="gastric varices: endotherapy" src="slide21.swf" size="20480" advanceOnTime="1" framesCount="1" hasEmbeddedFlashClip="0" hidden="0" level="0" advanceOnClick="1" thumbnailAssetId="imgAsset20" presenterIndex="0">
			<sounds/>
			<videos/>
			<transitionEffect name="" duration="0.0000000" soundId="" looped="0"/>
			<soundCommands/>
			<videoCommands/>
			<animationSteps>
				<step start="0" end="0" playTime="0.0010000" pauseTime="39.5790018"/>
			</animationSteps>
			<notes>Although well control  active bleeding, anyway let still a certain number of uncontrolled and recurrent bleeding 10-20%
Residual patency of treated varices correlated with risk of rebleeding after glue injection. Varix obliteration was also confirmed by the absence of blood flow on color Doppler.</notes>
			<notesNormalized>although well control active bleeding, anyway let still a certain number of uncontrolled and recurrent bleeding 10-20%
residual patency of treated varices correlated with risk of rebleeding after glue injection. varix obliteration was also confirmed by the absence of blood flow on color doppler.</notesNormalized>
			<notesHtml>&lt;p&gt;&lt;font size="12"&gt;Although well control  active bleeding, anyway let still a certain number of uncontrolled and recurrent bleeding 10-20%&lt;/font&gt;&lt;/p&gt;&lt;p&gt;&lt;font size="12"&gt;Residual patency of treated varices correlated with risk of rebleeding after glue injection. Varix obliteration was also confirmed by the absence of blood flow on color Doppler.&lt;/font&gt;&lt;/p&gt;</notesHtml>
			<text>Gastric Fundal Varices (GOV2/IGV1)
Initial hemostasis: 83%-100%
Re-bleeding: 8%-18%
Embolism 0.5-4.3% 
Post injection ulcer, scope damage
Fetal: case report* from cerebral and splenic embolization

Glue injection
Gastric varices: Endotherapy
Saraswat VA, Verma A. J Clin Exp Hepatol. 2012;2:55–69. 
*Ashraf P, et al. J Coll Physicians Surg Pak. 2011;21:574–576
*Martins Santos MM, et al. Gastrointest Endosc. 2007;65:1088–1090.</text>
		</slide>
		<slide index="21" title="Endotherapy for GVs: Why-EUS?" titleNormalized="endotherapy for gvs: why-eus?" src="slide22.swf" size="528679" advanceOnTime="1" framesCount="342" hasEmbeddedFlashClip="0" hidden="0" level="0" advanceOnClick="1" thumbnailAssetId="imgAsset21" presenterIndex="0">
			<sounds/>
			<videos>
				<video id="video5" videoClipId="ispring.resources_18cfaa80.spr0_6195517" slides="1" repeat="1" volume="0.8000000" posterFrameId="ispring.resources_18cfaa80.spr2_6195517" playFullScreen="0" hideWhenNotPlaying="0" rewindAfterPlaying="0"/>
			</videos>
			<transitionEffect name="" duration="0.0000000" soundId="" looped="0"/>
			<soundCommands/>
			<videoCommands>
				<playVideo frameIndex="0" videoId="video5" startPos="0.0000000"/>
			</videoCommands>
			<animationSteps>
				<step start="0" end="341" playTime="14.1999998" pauseTime="0.0000000"/>
			</animationSteps>
			<notes>However, these approaches are performed only varicers seen in endoscopy
use the exact location of the varix under or outside the wall of the esophagus and stomach cannot be observed directly. </notes>
			<notesNormalized>however, these approaches are performed only varicers seen in endoscopy
use the exact location of the varix under or outside the wall of the esophagus and stomach cannot be observed directly.</notesNormalized>
			<notesHtml>&lt;p&gt;&lt;font size="12"&gt;However, these approaches are performed only varicers seen in endoscopy&lt;/font&gt;&lt;/p&gt;&lt;p&gt;&lt;font size="12"&gt;use the exact location of the varix under or outside the wall of the esophagus and stomach cannot be observed directly. &lt;/font&gt;&lt;/p&gt;</notesHtml>
		</slide>
		<slide index="22" title="Endotherapy for GVs: Why-EUS?" titleNormalized="endotherapy for gvs: why-eus?" src="slide23.swf" size="23612" advanceOnTime="1" framesCount="1" hasEmbeddedFlashClip="0" hidden="0" level="0" advanceOnClick="1" thumbnailAssetId="imgAsset22" presenterIndex="0">
			<sounds/>
			<videos/>
			<transitionEffect name="" duration="0.0000000" soundId="" looped="0"/>
			<soundCommands/>
			<videoCommands/>
			<animationSteps>
				<step start="0" end="0" playTime="0.0010000" pauseTime="27.7089991"/>
			</animationSteps>
			<notes>However, these approaches are performed only varicers seen in endoscopy
use the exact location of the varix under or outside the wall of the esophagus and stomach cannot be observed directly. </notes>
			<notesNormalized>however, these approaches are performed only varicers seen in endoscopy
use the exact location of the varix under or outside the wall of the esophagus and stomach cannot be observed directly.</notesNormalized>
			<notesHtml>&lt;p&gt;&lt;font size="12"&gt;However, these approaches are performed only varicers seen in endoscopy&lt;/font&gt;&lt;/p&gt;&lt;p&gt;&lt;font size="12"&gt;use the exact location of the varix under or outside the wall of the esophagus and stomach cannot be observed directly. &lt;/font&gt;&lt;/p&gt;</notesHtml>
			<text>Endotherapy for GVs: Why-EUS
Courtesy: picture from istockphoto.com
Mehta G, Abraldes JG, Bosch J. Gut 2010;59:701-705. 
 drawing picture by Dr.Tanyaporn Chantarojanasiri
See more: 
 inflow/out flow
See more:
 obliteration
DO more
 material/technique</text>
		</slide>
		<slide index="23" title="GVs: EUS guided therapy" titleNormalized="gvs: eus guided therapy" src="slide24.swf" size="3490" advanceOnTime="1" framesCount="1" hasEmbeddedFlashClip="0" hidden="0" level="0" advanceOnClick="1" thumbnailAssetId="imgAsset23" presenterIndex="0">
			<sounds/>
			<videos/>
			<transitionEffect name="" duration="0.0000000" soundId="" looped="0"/>
			<soundCommands/>
			<videoCommands/>
			<animationSteps>
				<step start="0" end="0" playTime="0.0010000" pauseTime="18.2289995"/>
			</animationSteps>
			<notes/>
			<notesNormalized/>
			<notesHtml/>
			<text>Romero-Castro R, et al. Gastrointest Endosc 2007;66:402-7
Romero-Castro R, et al. Endoscopy 2010;42:;:E35-36
GVs: EUS guided therapy
GV: EUS guided injection
GV: EUS guided coil deployment
N-butyl-2-cyanoacrylate (Histoacryl)
2-octyl-cyanoacrylate (Dermabond)
Sclerosant
Glue


Others: thrombin,…
Levy MJ, et al. Gastrointest Endosc 2008;67:572-574
Irisawa A. APDW 2015</text>
		</slide>
		<slide index="24" title="EUS-guided GVs: Glue" titleNormalized="eus-guided gvs: glue" src="slide25.swf" size="1770" advanceOnTime="1" framesCount="1" hasEmbeddedFlashClip="0" hidden="0" level="0" advanceOnClick="1" thumbnailAssetId="imgAsset24" presenterIndex="0">
			<sounds/>
			<videos/>
			<transitionEffect name="" duration="0.0000000" soundId="" looped="0"/>
			<soundCommands/>
			<videoCommands/>
			<animationSteps>
				<step start="0" end="0" playTime="0.0010000" pauseTime="28.8690008"/>
			</animationSteps>
			<notes/>
			<notesNormalized/>
			<notesHtml/>
			<text>EUS-guided GVs: Glue 
Objective: to assess the efficacy
5 cases (2005-2006)
Cyanoacrylate-Lipiodol with 22G EUS needle
Target: perforating feeder veins (GV)
Result: successful GV eradication with less glue
 and no recurrent
 
Romero-Castro R, et al. Gastrointest Endosc. 2007; 66:402-7.</text>
		</slide>
		<slide index="25" title="GVs: EUS guided coil deployment" titleNormalized="gvs: eus guided coil deployment" src="slide26.swf" size="353514" advanceOnTime="1" framesCount="1734" hasEmbeddedFlashClip="0" hidden="0" level="0" advanceOnClick="1" thumbnailAssetId="imgAsset25" presenterIndex="0">
			<sounds/>
			<videos>
				<video id="video6" videoClipId="ispring.resources_18e0f8a0.spr0_6222895" slides="1" repeat="1" volume="0.8000000" posterFrameId="ispring.resources_18e0f8a0.spr2_6222895" playFullScreen="0" hideWhenNotPlaying="0" rewindAfterPlaying="0"/>
			</videos>
			<transitionEffect name="" duration="0.0000000" soundId="" looped="0"/>
			<soundCommands/>
			<videoCommands>
				<playVideo frameIndex="0" videoId="video6" startPos="0.0000000"/>
			</videoCommands>
			<animationSteps>
				<step start="0" end="1733" playTime="72.1999969" pauseTime="0.0000000"/>
			</animationSteps>
			<notes>Metal coils are covered with synthetic thrombotic material to promote clot aggregation</notes>
			<notesNormalized>metal coils are covered with synthetic thrombotic material to promote clot aggregation</notesNormalized>
			<notesHtml>&lt;p&gt;&lt;font size="12"&gt;Metal coils are covered with synthetic thrombotic material to promote clot aggregation&lt;/font&gt;&lt;/p&gt;</notesHtml>
		</slide>
		<slide index="26" title="GVs: EUS guided coil deployment" titleNormalized="gvs: eus guided coil deployment" src="slide27.swf" size="338096" advanceOnTime="1" framesCount="2399" hasEmbeddedFlashClip="0" hidden="0" level="0" advanceOnClick="1" thumbnailAssetId="imgAsset26" presenterIndex="0">
			<sounds/>
			<videos>
				<video id="video7" videoClipId="ispring.resources_18e0fa60.spr0_6258744" slides="1" repeat="1" volume="0.8000000" posterFrameId="ispring.resources_18e0fa60.spr2_6258744" playFullScreen="0" hideWhenNotPlaying="0" rewindAfterPlaying="0"/>
			</videos>
			<transitionEffect name="" duration="0.0000000" soundId="" looped="0"/>
			<soundCommands/>
			<videoCommands>
				<playVideo frameIndex="0" videoId="video7" startPos="0.0000000"/>
			</videoCommands>
			<animationSteps>
				<step start="0" end="2398" playTime="99.8529968" pauseTime="0.0000000"/>
			</animationSteps>
			<notes>Metal coils are covered with synthetic thrombotic material to promote clot aggregation</notes>
			<notesNormalized>metal coils are covered with synthetic thrombotic material to promote clot aggregation</notesNormalized>
			<notesHtml>&lt;p&gt;&lt;font size="12"&gt;Metal coils are covered with synthetic thrombotic material to promote clot aggregation&lt;/font&gt;&lt;/p&gt;</notesHtml>
		</slide>
		<slide index="27" title="EUS-guided GVs: Coil vs Glue" titleNormalized="eus-guided gvs: coil vs glue" src="slide28.swf" size="3006" advanceOnTime="1" framesCount="1" hasEmbeddedFlashClip="0" hidden="0" level="0" advanceOnClick="1" thumbnailAssetId="imgAsset27" presenterIndex="0">
			<sounds/>
			<videos/>
			<transitionEffect name="" duration="0.0000000" soundId="" looped="0"/>
			<soundCommands/>
			<videoCommands/>
			<animationSteps>
				<step start="0" end="0" playTime="0.0010000" pauseTime="48.3090014"/>
			</animationSteps>
			<notes/>
			<notesNormalized/>
			<notesHtml/>
			<text>EUS-guided GVs: Coil vs Glue 
Romero-Castro R, et al. Gastrointest Endosc 2013;78:711-721
Retrospective analysis of a prospective maintained database, multicenter study
11 patients: coil group vs 19 patients CYA group
Inclusion criteria: bleeding GV, ASAI-III, Exclusion: disfuse GV, Plt&lt;50,000, INR&gt;2, SV thrombosis, 
Esophageal-stricture
Under Propofol, Antibiotic, Ambulatory care, F/U Wk1-Month6
 Approach: Trans-esophageal or trans-gastric
Technique: Coil-stainless steel synthetic fibered coil(MREYE, IMWCE (Cook), diameter 8-20mm; 
 straight length of 50-150 mm, 3.2-5.6 configuration loops
 a mean of 5.8+/-1.2 coils (2-13) per patient

 CYA- a mixture of N-bytyl-2-cyanoacrylate with lipiodol (1:1) 1ml/portion 
 at perforating vein with 22G needle
 a mean 1.5+/- 0.1 ml (1-3) CYA use
Vessel thrombosis: : Doppler –ve, flow downstream by contrast injection 
Perforating veins diameter range from 3-25 mm (10.5+/-0.8) 
CYA Gr.: more Child-Pugh Class and more history of previous bleeding</text>
		</slide>
		<slide index="28" title="EUS-guided GVs: Coil vs Glue" titleNormalized="eus-guided gvs: coil vs glue" src="slide29.swf" size="3058" advanceOnTime="1" framesCount="1" hasEmbeddedFlashClip="0" hidden="0" level="0" advanceOnClick="1" thumbnailAssetId="imgAsset28" presenterIndex="0">
			<sounds/>
			<videos/>
			<transitionEffect name="" duration="0.0000000" soundId="" looped="0"/>
			<soundCommands/>
			<videoCommands/>
			<animationSteps>
				<step start="0" end="0" playTime="0.0010000" pauseTime="59.8290018"/>
			</animationSteps>
			<notes/>
			<notesNormalized/>
			<notesHtml/>
			<text>EUS-guided GVs: Coil vs Glue 
Romero-Castro R, et al. Gastrointest Endosc 2013;78:711-721
Over all obliteration: 29/30: (one case-technical difficulty due to complex anatomy)
Coil Gr.: 10/11-90.9% (14 sessions) vs CYA Gr.: 19/19-100% (29 sessions)
 9/11 (81.8%) one session 10/19 (52.6%) one session 
 1/11 (9.1%) two sessions 8/19 (42.1%) two sessions
 1/11 (9.1%) three sessions 1/19 (5.3%) three sessions
 2/11 (18.2%) additional with CYA 
All obtained hemostasis and no recurrent 
 Adverse event: overall 12/30 (40%)
Coil Gr.: 1/9 (9.1%, 95% CI 7.9%-26.1%) vs CYA Gr.: 11/19* (57.9%, 35.7%-80.1%) p&lt;0.01

Coil: 1 symptom-esophageal bleeding
CYA: 2 symptom-fever, chest pain without embolism
 9 asymptomatic pulmonary embolism (CT)
* Including asymptomatic pulmonary embolism
Hospital stay: Coil 6.0+/-2.4 D vs CYA 17.3+/-2.7 D, p=0.007
Cost per procedure: more expensive in Coil</text>
		</slide>
		<slide index="29" title="Coil Migration" titleNormalized="coil migration" src="slide30.swf" size="72285" advanceOnTime="1" framesCount="1" hasEmbeddedFlashClip="0" hidden="0" level="0" advanceOnClick="1" thumbnailAssetId="imgAsset29" presenterIndex="0">
			<sounds/>
			<videos/>
			<transitionEffect name="" duration="0.0000000" soundId="" looped="0"/>
			<soundCommands/>
			<videoCommands/>
			<animationSteps>
				<step start="0" end="0" playTime="0.0010000" pauseTime="21.3390002"/>
			</animationSteps>
			<notes/>
			<notesNormalized/>
			<notesHtml/>
			<text>Coil Migration</text>
		</slide>
		<slide index="30" title="Coil Migration: Prevention" titleNormalized="coil migration: prevention" src="slide31.swf" size="180443" advanceOnTime="1" framesCount="884" hasEmbeddedFlashClip="0" hidden="0" level="0" advanceOnClick="1" thumbnailAssetId="imgAsset30" presenterIndex="0">
			<sounds/>
			<videos>
				<video id="video8" videoClipId="ispring.resources_22674790.spr0_6273845" slides="1" repeat="1" volume="0.8000000" posterFrameId="ispring.resources_22674790.spr2_6273845" playFullScreen="0" hideWhenNotPlaying="0" rewindAfterPlaying="0"/>
			</videos>
			<transitionEffect name="" duration="0.0000000" soundId="" looped="0"/>
			<soundCommands/>
			<videoCommands>
				<playVideo frameIndex="0" videoId="video8" startPos="0.0000000"/>
			</videoCommands>
			<animationSteps>
				<step start="0" end="883" playTime="36.7916667" pauseTime="0.0083326"/>
			</animationSteps>
			<notes/>
			<notesNormalized/>
			<notesHtml/>
		</slide>
		<slide index="31" title="EUS-guided GVs: Coil plus Glue" titleNormalized="eus-guided gvs: coil plus glue" src="slide32.swf" size="8833" advanceOnTime="1" framesCount="1" hasEmbeddedFlashClip="0" hidden="0" level="0" advanceOnClick="1" thumbnailAssetId="imgAsset31" presenterIndex="0">
			<sounds/>
			<videos/>
			<transitionEffect name="" duration="0.0000000" soundId="" looped="0"/>
			<soundCommands/>
			<videoCommands/>
			<animationSteps>
				<step start="0" end="0" playTime="0.0010000" pauseTime="60.0390009"/>
			</animationSteps>
			<notes>Binmoeeler postulated coil will provide a scaffold for glue adherence</notes>
			<notesNormalized>binmoeeler postulated coil will provide a scaffold for glue adherence</notesNormalized>
			<notesHtml>&lt;p&gt;&lt;font size="12"&gt;Binmoeeler postulated coil will provide a scaffold for glue adherence&lt;/font&gt;&lt;/p&gt;</notesHtml>
			<text>EUS-guided GVs: Coil plus Glue 
Authors study period Design Cases success no.coil vol.CYA F/U(Day) Obliteration Adverse event
 rate ml pain bleeding embolism

Bhat YM 2009-2015 Retro 152 GFV 151(99%) 1.4 (1-4) 2 (0.5-6) 436 (30-2043) 93 (93%) 3% 3% 1%
 7(5%) active bleed
 105 (69%) recent bleeding
 40(26%) primary prophylaxis 96%




Binmoeller 2009-2011 Retro 30 GFV# 100% 1.4/varix 96%
 2 active bleed (single session)
(transesophageal approach) 14 recent bleed

# not good candidate for TIPSS 
Bhat YM, et al. GIE 2016;83:1164-72
Binmoeller KF, et al. GIE 2011;74:1019-25.
“Coil can provide a scaffold for glue adherence* to decrease risk of migration”
Hall PSJ , et al. Clin Endosc 2017;50:138-142</text>
		</slide>
		<slide index="32" title="EUS-guided GVs: Coil plus Sclerosant" titleNormalized="eus-guided gvs: coil plus sclerosant" src="slide33.swf" size="8426" advanceOnTime="1" framesCount="1" hasEmbeddedFlashClip="0" hidden="0" level="0" advanceOnClick="1" thumbnailAssetId="imgAsset32" presenterIndex="0">
			<sounds/>
			<videos/>
			<transitionEffect name="" duration="0.0000000" soundId="" looped="0"/>
			<soundCommands/>
			<videoCommands/>
			<animationSteps>
				<step start="0" end="0" playTime="0.0010000" pauseTime="30.2989992"/>
			</animationSteps>
			<notes/>
			<notesNormalized/>
			<notesHtml/>
			<text>EUS-guided GVs: Coil plus Sclerosant 
Irisawa A. APDW 2015
Deploy coil till blocked variceal blood flow
 (confirmed by contrast varicealopgrphy)
Injected sclerosant (ethanolamine oleate)
 Into varix including feeders
6 patients was performed with 
 100% success with no minor/major complication</text>
		</slide>
		<slide index="33" title="EUS-guided creation of an Intrahepatic Portosystemic Shunt" titleNormalized="eus-guided creation of an intrahepatic portosystemic shunt" src="slide34.swf" size="100208" advanceOnTime="1" framesCount="1" hasEmbeddedFlashClip="0" hidden="0" level="0" advanceOnClick="1" thumbnailAssetId="imgAsset33" presenterIndex="0">
			<sounds/>
			<videos/>
			<transitionEffect name="" duration="0.0000000" soundId="" looped="0"/>
			<soundCommands/>
			<videoCommands/>
			<animationSteps>
				<step start="0" end="0" playTime="0.0010000" pauseTime="32.5089983"/>
			</animationSteps>
			<notes/>
			<notesNormalized/>
			<notesHtml/>
			<text>                                                                                                     
Figure 3
Stent located between hepatic and portal vein on necropsy.

Schulman AR, et al.Gastrointestinal endoscopy. 2017;85:243-247. 
EUS-guided creation of an Intrahepatic Portosystemic Shunt
Buscaglia JM. A Gastrointest Endosc. 2009;69(4):941–947</text>
		</slide>
		<slide index="34" title="EUS for portal hypertension and varix management" titleNormalized="eus for portal hypertension and varix management" src="slide35.swf" size="1666" advanceOnTime="1" framesCount="1" hasEmbeddedFlashClip="0" hidden="0" level="0" advanceOnClick="1" thumbnailAssetId="imgAsset34" presenterIndex="0">
			<sounds/>
			<videos/>
			<transitionEffect name="" duration="0.0000000" soundId="" looped="0"/>
			<soundCommands/>
			<videoCommands/>
			<animationSteps>
				<step start="0" end="0" playTime="0.0010000" pauseTime="41.7390017"/>
			</animationSteps>
			<notes/>
			<notesNormalized/>
			<notesHtml/>
			<text>EUS for portal hypertension 
and varix management
 In summary: Recently, EUS has played role in case of 
unsecured EG variceal bleeding, recurrent bleeding in aspect of 
detecting deep collateral pathway-perforating veins (afferent),
targeting with glue/coil deployment and confirming vessel obliteration 
as well. Furthermore, more trial in PPG measure and Intrahepatic 
portosystemic shunt may be bright future in clinical practice.</text>
		</slide>
	</slides>
</presentation>
